Mediterranean Diet Lowered Inflammation Markers and Reshaped the Gut Microbiome in 612 Older Adults

The Mediterranean diet is best known for cardiovascular outcomes, but the NU-AGE trial asked a different question: can a year of Mediterranean eating change the gut microbiome of older adults -- and do those microbial changes track with frailty, inflammation, and cognition? Published in Gut in 2020, this randomized dietary intervention followed 612 adults aged 65 to 79 across five European countries and found that diet-responsive gut bacteria were associated with reduced frailty markers, better cognitive performance, and lower inflammatory markers including C-reactive protein. It remains the largest long-duration trial connecting the Mediterranean diet -- with its signature load of olive polyphenols -- to the aging gut microbiome.

Why This Study Matters

Most diet-microbiome studies share two limitations: they are small, and they are short. A typical intervention runs a few weeks in a few dozen people -- long enough to show the microbiome responds to food, too short to say anything about health outcomes that matter.

NU-AGE was built differently. It enrolled older adults specifically -- a population whose gut microbiome tends to lose diversity with age, a shift that has been linked to frailty, inflammation, and decline. And it asked whether a sustained, realistic dietary change could push the aging microbiome in the other direction, and whether the people whose microbiomes responded were also the people whose health markers improved.

The five-country design matters more than it may look. Baseline gut microbiomes differ substantially between, say, Poland and Italy, because habitual diets differ. Finding a consistent microbiome response to the same intervention across all five countries is built-in replication -- the kind most single-site studies cannot offer.

How It Was Designed

This analysis comes from the NU-AGE randomized controlled trial (registered as NCT01754012), which randomized older adults to a tailored Mediterranean-style diet or their habitual diet for 12 months. The microbiome substudy profiled 612 participants aged 65 to 79 -- non-frail or pre-frail at baseline -- in the UK, France, the Netherlands, Italy, and Poland, with stool samples sequenced at baseline and again at 12 months.

The intervention was individually tailored to each country's food culture rather than a one-size-fits-all menu, which is part of why adherence held up over a full year. Adherence was scored, and the analysis linked the degree of dietary adherence to the degree of microbiome change -- a dose-response style approach rather than a simple group comparison.

What They Found

Greater adherence to the diet produced a consistent microbiome shift, and that shift tracked with health markers:

Outcome	Direction	What It Measures
Gait speed and hand-grip strength	Positively associated with diet-responsive bacteria	Physical resilience / frailty risk
Fried frailty score	Inversely associated	Overall frailty index
C-reactive protein (CRP)	Decreased with adherence	Systemic inflammation
Interleukin-17 (IL-17)	Decreased with adherence	Inflammatory signaling
Cognitive measures (constructional praxis, episodic memory)	Positively associated	Cognitive function
Predicted short-chain fatty acid production	Increased	Beneficial microbial metabolites
Secondary bile acids and p-cresol	Decreased	Potentially harmful microbial metabolites

Directions shown are the statistically significant associations reported in the published analysis. Metabolite outputs were inferred from microbiome profiles.

Reading the Results

Which bacteria responded. The taxa enriched by the diet read like a who's-who of beneficial gut residents: Faecalibacterium prausnitzii, Roseburia hominis, and Eubacterium species -- the fiber-fermenting, butyrate-producing bacteria that gut researchers consistently find in healthier microbiomes. The taxa that declined -- including Ruminococcus torques and Collinsella aerofaciens -- are ones repeatedly associated with inflammation and metabolic dysfunction in other cohorts.

Position in the network, not just abundance. One of the study's most cited findings is structural: the diet-enriched bacteria occupied keystone positions in the gut's microbial interaction network -- hubs the rest of the ecosystem organizes around -- while the frailty-associated taxa sat at the periphery. A diet that strengthens the hubs is shifting the whole ecosystem, not just individual species counts.

What the bacteria were doing. The microbiome shift came with a predicted metabolic shift: more short-chain fatty acid production (the compounds that feed the gut lining and regulate immune tone) and less production of secondary bile acids and p-cresol, metabolites that at elevated levels have been linked to gut and metabolic harm.

The honest caveat. The links between diet-responsive bacteria and health markers are associations within a randomized trial -- the randomization proves the diet changed the microbiome, but the taxa-to-outcome connections are correlational. The study shows the microbiome moved with the diet and that health markers moved with the microbiome. It stops short of proving the bacteria caused the improvements.

What Didn't Change

The diet did not remake the microbiome wholesale. Overall community composition remained recognizably individual, and the changes concentrated in a specific set of diet-responsive taxa rather than a broad diversity surge. Baseline microbiomes also remained distinct by country -- the intervention nudged five different microbial starting points in the same direction rather than converging them into one profile.

Broader Context

The Mediterranean diet has the deepest outcome literature of any dietary pattern -- PREDIMED alone linked it (supplemented with extra virgin olive oil) to roughly 30% fewer major cardiovascular events. But most of that literature measures hearts and arteries. NU-AGE is the study that extended the evidence to the aging gut, and it did so with the two things microbiome research usually lacks: duration and scale.

It also fits a growing picture of how olive polyphenols and gut bacteria interact -- polyphenols that reach the colon are metabolized by gut microbes, and early trials suggest phenol-rich diets may support beneficial genera. Our full breakdown of that evidence is in Is Olive Oil Good for Gut Health?

What sets NU-AGE apart from prior work: a full year of intervention (most microbiome studies run weeks), 612 sequenced participants (most run dozens), five-country replication, and an older population -- the demographic where microbiome decline and frailty actually intersect.

Related Research

Continue exploring olive oil, polyphenol, and microbiome science:

• Higher Polyphenol Levels Linked to 29% Lower Inflammation
• Gut Microbiome Explains 6% of Triglyceride Variance in 893 Adults
• PREDIMED-Barcelona: Mediterranean Diet + EVOO and Cognitive Function Over 4 Years
• Can a Polyphenol-Rich Diet Slow Biological Aging? An 18-Month Trial

Source: View the original study on PubMed

Olivea's Dosage

This trial tested a whole diet rather than a single compound, so there is no supplement dose to compare. Olive oil is the Mediterranean diet's signature fat, and its polyphenols -- led by hydroxytyrosol -- are among the compounds researchers point to when explaining the diet's effects. Each Olivea capsule delivers over 20 mg of hydroxytyrosol per serving; our most recent third-party certificate of analysis confirmed 23.5 mg per capsule.

We share this research for transparency. This is an independent study -- we did not fund it, design it, or conduct it.

Editorial Information

Research note. This article summarizes third-party research published in a peer-reviewed journal. Olivea did not conduct or fund the study. Findings reflect the cited paper only and do not establish efficacy of Olivea products.

.